| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.89▼ | 2.88▼ | 2.87▼ | 3.10▼ | 3.14▼ |
| MA10 | 2.89▼ | 2.85▲ | 2.87▲ | 3.11▼ | 3.18▼ |
| MA20 | 2.90▼ | 2.87▲ | 2.94▼ | 3.30▼ | 3.23▼ |
| MA50 | 2.87▲ | 3.01▼ | 3.12▼ | 3.22▼ | 3.55▼ |
| MA100 | 2.86▲ | 3.12▼ | 3.18▼ | 3.26▼ | 3.27▼ |
| MA200 | 2.93▼ | 3.21▼ | 3.35▼ | 3.50▼ | 6.55▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | 0.017▲ | 0.003▲ | -0.049▼ | -0.021▼ |
| RSI | 43.371▼ | 43.644▼ | 35.114▼ | 39.294▼ | 43.130▼ |
| STOCH | 33.433 | 78.798 | 44.821 | 34.797 | 31.473 |
| WILL %R | -100.000▼ | -44.444 | -82.759▼ | -87.421▼ | -92.874▼ |
| CCI | -128.180▼ | 57.726 | -23.646 | -185.734▼ | -108.453▼ |
|
Friday, September 25, 2026 05:41 AM
Prime Medicine, Inc. (Nasdaq: PRME) has received U.S. FDA clearance to begin clinical testing of PM647, a gene-editing therapy designed to treat Alpha-1 Antitrypsin Deficiency, marking another ...
|
|
Thursday, September 24, 2026 01:47 PM
Prime Medicine Inc (NASDAQ:PRME) shares gained over 12% in after-hours trading Thursday following the FDA's clearance of the company's Investigational New Drug application for PM647, an in vivo gene ...
|
|
Thursday, September 24, 2026 12:59 AM
Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that the U.S. Food and Drug ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/09/26 | 2.84 | 2.92 | 2.77 | 2.87 | 3,421,231 |
| 25/09/26 | 3.42 | 3.44 | 2.875 | 2.90 | 7,069,730 |
| 24/09/26 | 3.11 | 3.13 | 2.9901 | 3.07 | 4,485,368 |
| 23/09/26 | 3.53 | 3.53 | 3.12 | 3.13 | 3,316,255 |
| 22/09/26 | 3.22 | 3.565 | 3.20 | 3.54 | 2,714,194 |
| 21/09/26 | 3.19 | 3.27 | 3.10 | 3.19 | 2,946,303 |
| 18/09/26 | 3.13 | 3.17 | 3.045 | 3.12 | 4,598,669 |
| 17/09/26 | 3.11 | 3.39 | 3.10 | 3.14 | 3,253,757 |
| 16/09/26 | 3.18 | 3.22 | 2.93 | 3.00 | 3,286,580 |
| 15/09/26 | 3.18 | 3.22 | 3.00 | 3.14 | 2,572,024 |
|
|
||||
|
|
||||
|
|